Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890107 · ClinicalTrials.gov registry record
Clinical Evaluation of the OtoSight
A clinical trial, sponsored by PhotoniCare.
- Completed
- Registry status
- 110
- Enrollment target
NCT03890107 is a clinical trial that has completed, run by PhotoniCare. The registered enrollment target is 110 participants.
The verdict
NCT03890107 has completed, sponsored by PhotoniCare.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the imaging capabilities and image analysis performance of the OtoSight Middle Ear Scope in pediatric patients undergoing tympanostomy tube placement for otitis media. In this observational study, results of OtoSight imaging will not affect patient standard of care.
Interventions
- DEVICE OtoSight Middle Ear Scope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2022-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03890107
The ClinicalTrials.gov registry entry for NCT03890107 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhotoniCare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OtoSight Middle Ear Scope is the first listed.
NCT03890107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03890107 about?
NCT03890107 is a clinical study titled "Clinical Evaluation of the OtoSight". The objective of this study is to evaluate the imaging capabilities and image analysis performance of the OtoSight Middle Ear Scope in pediatric patients undergoing tympanostomy tube placement for otitis media. In this observational study, results of OtoSight imaging will not affect patient standard...
What is the current status of trial NCT03890107?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2019-04-15. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT03890107?
The interventions under investigation include: OtoSight Middle Ear Scope (DEVICE).
Who is sponsoring clinical trial NCT03890107?
This trial is sponsored by PhotoniCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.